• TechCrunch
• CrunchBase
• More
  • TechCrunch Europe
  • TechCrunch France
  • TechCrunch Japan

Mira Dx

edit

Mira Dx is a genomics company dedicated to the development and commercialization of novel microRNA-based diagnostic tests. The company’s goal is to help clinicians better understand cancer and enhance decision making.

Milestones

edit

• 
  Mira Dx added Barbara Mignogna-Korus as COO.
  Posted 10/31/10 at 8:54pm
• 
  Mira Dx added Stephen Miller as President.
  Posted 10/31/10 at 8:54pm
• 
  Mira Dx received $4M in Series A funding. (7/1/10)
  Posted 10/31/10 at 8:54pm via massdevice.com

Videos

Screenshots

edit

Sources

1. Mira Dx boosts Series A round with $1 million from Connecticut Innovations (massdevice.com) [edit]